:ﺔﻣﺎﻋ تﺎﻣوﻠﻌﻣ .لﻣﺣﻟا ةرﺗﻓ لﻼﺧ ةرﻣ لوﻷ ﮫﯾﻠﻋ فرﻌﺗﻟا مﺗﯾ زوﻛوﻠﺟﻟا لﻣﺣﺗ لﻼﺗﺧﻻ ﺔﺟرد يأ وھ (GDM) ﻲﻠﻣﺣﻟا يرﻛﺳﻟا ءاد ﻰﻠﻋو ؛مﮭﻟﺎﻔطأ ةدﻻو دﻌﺑ يدﺎﻌﻟا زوﻛوﻠﺟﻟا بﻼﻘﺗﺳا ﻰﻟإ (GDM) ﻲﻠﻣﺣﻟا يرﻛﺳﻟا ءادﺑ ﺔﺑﺎﺻﻣﻟا ءﺎﺳﻧﻟا مظﻌﻣ دوﻌﯾ .مﮭﺗﯾرذ كﻟذﻛو مﮭﺗﺎﯾﺣ نﻣ قﺣﻻ تﻗو ﻲﻓ 2 عوﻧﻟا نﻣ يرﻛﺳﻟا ءادﺑ ﺔﺑﺎﺻﻹا رطﺧﻟ نوﺿرﻌﻣ مﮭﻧﺈﻓ ،كﻟذ نﻣ مﻏرﻟا تﺎﺳﺎﯾﺳﻟﺎﺑ ﺔﻘﻠﻌﺗﻣﻟا ﺔﯾﮭﯾﺟوﺗﻟا ئدﺎﺑﻣﻟا ﻊﻣ دﻠﺑﻟا ﻲﻓ (GDM) ﻲﻠﻣﺣﻟا يرﻛﺳﻟا ءاد رﺎﺷﺗﻧا لدﻌﻣ دﯾدﺣﺗ دﻋﺎﺳﯾ نأ نﻛﻣﯾو .ثﺣﺑﻟا بﻠطﺗﺗ ﻲﺗﻟا تﻻﺎﺟﻣﻟا ﻰﻠﻋ ءوﺿﻟا طﻠﺳﯾ نأ نﻛﻣﯾو ، (GDM)ﻲﻠﻣﺣﻟا يرﻛﺳﻟا ءاد ةرادإو صﺣﻔﺑ قﻠﻌﺗﯾ ﺎﻣﯾﻓ .ﺎﯾﻘﯾرﻓأ ﻲﻓ (GDM) ﻲﻠﻣﺣﻟا يرﻛﺳﻟا ءاد رﺎﺷﺗﻧا مﯾﯾﻘﺗﺑ ﻲﺟﮭﻧﻣﻟا ضارﻌﺗﺳﻻا اذھ موﻘﯾو

1. .‫ﻣﻧﮭﺟﻲ‬ ‫ض‬‫ا‬‫ر‬ ‫ﺳﺗﻌ‬ ‫ا‬:‫ﻓرﯾﻘﯾﺎ‬ ‫ﻓﻲأ‬ ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ي‬‫ر‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ء‬‫ا‬‫د‬
‫ﻣﻠﺧص‬
:‫ﻋﺎﻣﺔ‬ ‫ﻣﻌﻠوﻣﺎت‬
.‫ﻟﺣﻣل‬ ‫ا‬‫ةر‬ ‫ﻓﺗ‬ ‫ﺧﻼل‬ ‫ﻣةر‬ ‫ﻷلو‬ ‫ﻋﻠﯾﮫ‬ ‫ﻟﺗﻌفر‬ ‫ا‬‫م‬ ‫ﯾﺗ‬ ‫ﻟﺟﻠوﻛزو‬ ‫ا‬‫ل‬ ‫ﺗﺣﻣ‬ ‫ﻻﺧﺗﻼل‬ ‫ﺟﺔ‬ ‫رد‬‫يأ‬‫وھ‬ (GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬ ‫ﻋﻠﻰ‬ ‫و‬‫؛‬‫م‬ ‫ﻔﺎﻟﮭ‬ ‫طأ‬‫ةد‬ ‫ﻻ‬ ‫و‬‫د‬ ‫ﺑﻌ‬ ‫ﻟﻌﺎيد‬ ‫ا‬‫زو‬ ‫ﻟﺟﻠوﻛ‬ ‫ا‬‫ب‬ ‫ﺳﺗﻘﻼ‬ ‫ﻟﻰا‬ ‫(إ‬GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬
‫ﺑءاد‬ ‫ﻟﻣﺻﺎﺑﺔ‬ ‫ا‬‫ء‬ ‫ﻟﻧﺳﺎ‬ ‫ا‬‫مظ‬ ‫ﻣﻌ‬ ‫ﯾﻌدو‬
.‫ﯾﺗﮭم‬ ‫رذ‬‫ك‬ ‫ﻛذﻟ‬ ‫و‬‫م‬ ‫ﺣﯾﺎﺗﮭ‬ ‫ﻣن‬ ‫ﻻﺣق‬ ‫ﻗت‬ ‫ﻓﻲو‬ 2 ‫ﻟﻧعو‬ ‫ا‬‫ن‬ ‫ﻣ‬ ‫ﻟﺳﻛير‬ ‫ا‬‫ءاد‬ ‫ﺑ‬ ‫ﻹﺻﺎﺑﺔ‬ ‫ا‬‫رط‬ ‫ﻟﺧ‬ ‫ﻣﻌرﺿنو‬ ‫ﻓﺈﻧﮭم‬ ،‫ك‬ ‫ﻟ‬ ‫ذ‬‫ن‬ ‫ﻣ‬ ‫ﻟرﻏم‬ ‫ا‬‫ت‬ ‫ﺑﺎﻟﺳﯾﺎﺳﺎ‬ ‫ﻟﻣﺗﻌﻠﻘﺔ‬ ‫ﻟﺗوﺟﯾﮭﯾﺔا‬ ‫ا‬‫ئد‬ ‫ﻟﻣﺑﺎ‬ ‫ﻣﻊا‬ ‫ﻟﺑﻠد‬ ‫ﻓﻲا‬ (GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬
‫ﻧﺗﺷﺎر‬ ‫ا‬‫لد‬ ‫ﻣﻌ‬ ‫ﺗﺣدﯾد‬ ‫ﯾﺳﺎﻋد‬ ‫نأ‬‫ن‬ ‫وﯾﻣﻛ‬
.‫ﻟﺑﺣث‬ ‫ا‬‫ب‬ ‫ﺗﺗطﻠ‬ ‫ﻟﺗﻲ‬ ‫ا‬‫ت‬ ‫ﻟﻣﺟﺎﻻ‬ ‫ﻋﻠﻰا‬ ‫ﻟﺿءو‬ ‫ا‬‫ط‬ ‫ﯾﺳﻠ‬ ‫نأ‬‫ن‬ ‫ﯾﻣﻛ‬ ‫و‬، (GDM)‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬‫ةرادإو‬‫ص‬ ‫ﺑﻔﺣ‬ ‫ﯾﺗﻌﻠق‬ ‫ﻓﯾﻣﺎ‬
.‫ﻓرﯾﻘﯾﺎ‬ ‫ﻓﻲأ‬ (GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬‫ر‬ ‫ﻧﺗﺷﺎ‬ ‫ا‬‫م‬ ‫ﺑﺗﻘﯾﯾ‬ ‫ﻟﻣﻧﮭﺟﻲ‬ ‫ا‬‫ضار‬ ‫ﻻﺳﺗﻌ‬ ‫ا‬‫اذھ‬‫مو‬ ‫وﯾﻘ‬
:‫ﻟﻧﺗﺎﺋﺞ‬ ‫او‬‫قرط‬ ‫ﻟ‬ ‫ﻣﻛﺗﺑﺔا‬ ‫و‬Scopus ‫ﺳﻛوﺑسو‬ ‫و‬PubMed ‫ﺑوﺑﻣد‬ ‫ﻟﻐوﯾﺔ؛‬ ‫ﻗﯾدو‬ ‫ﻟﻛﺗورﻧﯾﺔنود‬ ‫إ‬‫ت‬ ‫ﺑﯾﺎﻧﺎ‬
‫ﻗاوﻋد‬ ‫ﺛﻼث‬ ‫ﻓﻲ‬ ‫ﻟﺑﺣث‬ ‫ا‬‫م‬ ‫ﺗ‬ ‫و‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬ ‫ﻟﻣﻧﺎﺳﺑﺔ‬ ‫ا‬‫ت‬ ‫ﻟﻣﻘﺎﻻ‬ ‫ا‬‫تدد‬ ‫ﺣ‬ .‫ﺑﺣث‬ ‫ﻋﺑﺎةر‬ ‫ﺛﻼﺛﯾن‬ ‫و‬‫د‬ ‫ﺣ‬ ‫او‬‫ن‬ ‫ﻋ‬ ‫ﻟﺑﺣث‬ ‫ا‬‫م‬ ‫ﺗ‬ .Cochrane Library ‫ﻛوﻛرﯾن‬ ‫ءاد‬‫ر‬ ‫ﻧﺗﺷﺎ‬ ‫ا‬‫ن‬ ‫ﻋ‬ ‫ﺗﻘﺎرﯾر‬ ‫ﻋتد‬ ‫أو‬‫مد‬ ‫ﻟﻣﺳﺗﺧ‬ ‫(ا‬GDM)
‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬‫زر‬ ‫ﻓ‬ ‫ﻧﮭﺞ‬ ‫ﻲ‬ ‫ﻣﺎھ‬ ‫ﻛتر‬ ‫ذو‬، (GDM)‫اﻟﺣﻣﻠﻲ‬
‫ﻓﯾﻣﺎ‬ PRISMA ‫ﻣﺑﺎئد‬ ‫ﺗﺑﻌت‬ ‫ا‬‫د‬ ‫ﻗ‬ ‫ﺳﺔ.و‬ ‫ارد‬‫ل‬ ‫ﻛ‬ ‫ﻓﻲ‬ ‫ﻟﺗﺣﯾز‬ ‫ا‬‫رط‬ ‫ﻣﺧﺎ‬ ‫و‬‫ر‬ ‫ﻟﺗﻘﺎرﯾ‬ ‫ا‬‫ةدو‬ ‫ﺟ‬ ‫ﺗﻘﯾﯾم‬ ‫ﺗم‬ .(GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫م‬ ‫ﺗ‬ ‫ﻛﺎﻣﻼ‬ ‫ﻧﺻﯾﺎ‬ ‫ﻣﻘﺎﻻ‬ ‫ﺳﺗﯾن‬ ‫ﺳﺗﻌضار‬ ‫ا‬‫ىر‬ ‫ﺟ‬ .‫ﻣﻧﻔادر‬ ‫ﺳﺟﻼ‬ 466 ‫ﻟﻣرﺟﻌﻲ‬ ‫ا‬
‫ﻟﺑﺣث‬ ‫ا‬‫دد‬ ‫ﺣ‬ .‫ﻟﻣﻧﮭﺟﯾﺔ‬ ‫ا‬‫ت‬ ‫ﺑﺎﻻﺳﺗﻌارﺿﺎ‬ ‫ﯾﺗﻌﻠق‬ ‫ﺗم‬ ‫ﻗد‬ ‫ﻟﻛﺎﻣل.و‬ ‫ﻧﺻﮫا‬ ‫ﻋﻠﻰ‬ ‫ﻟﺣﺻلو‬ ‫ا‬‫ن‬ ‫ﯾﻣﻛ‬ ‫ﻻ‬ ،‫د‬ ‫ﺣ‬ ‫او‬‫ص‬ ‫ﻣﻠﺧ‬ ‫ﯾﺿﺎ‬ ‫أ‬‫جردأو‬ .‫ﻟﻣﻧﮭﺟﻲ‬ ‫ا‬‫ضار‬ ‫ﻻﺳﺗﻌ‬ ‫ﻓﻲا‬ ‫ﻣﻧﮭﺎ‬ 14 ‫ﺛﯾوﺑﯾﺎجاردا‬ ‫أ‬‫؛‬ ‫ﻓرﯾﻘﯾﺔ‬ ‫أ‬‫ناد‬ ‫ﺑﻠ‬ ‫ﻟﺳت‬ ‫ﻧﺗﺷﺎھر‬ ‫او‬
‫ﻟﻔزر‬ ‫ا‬‫قرطو‬ (GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬‫ف‬ ‫ﺗﺻﻧﯾ‬ ‫ﻋن‬ ‫ﻣﻌﻠوﻣﺎت‬ ‫ﻋﻠﻰ‬ ‫اﻟﺣﺻلو‬
.(n = 1) ‫ﺗﻧازﻧﯾﺎ‬ ‫(و‬n= 4) ‫ﻓرﯾﻘﯾﺎ‬ ‫أ‬‫بو‬ ‫ﺟﻧ‬ ‫(و‬n = 6) ‫ﻧﯾﺟﯾرﯾﺎ‬ ‫(و‬n = 1) ‫ﻣزوﻣﺑﯾق‬ ‫(و‬n = 1) ‫ﻟﻣﻐبر‬ ‫(او‬n = 1) ‫ﻟﺗﻲ‬ ‫ا‬‫ء‬ ‫ﻟﻧﺳﺎ‬ ‫ﻋﻠﻰا‬ ‫ﺗرﻛز‬ ‫ﻟﺗﻲ‬ ‫ا‬‫ت‬ ‫ﻟاردﺳﺎ‬ ‫ا‬‫ض‬ ‫ﺑﻌ‬ ‫ﻣﻊ‬ (‫)ﻧﯾﺟﯾرﯾﺎ‬ ٪13.9 ‫ﻟﻰ‬ ‫إ‬
(‫)ﺗﻧازﻧﯾﺎ‬ ٪0 ‫ﻣن‬ ‫ﻻﻧﺗﺷﺎر‬ ‫ا‬‫ت‬ ‫ﻣﻌدﻻ‬ ‫وﺗوارﺣت‬
‫ﻋن‬ ‫ﻟﺟﻠوﻛزو‬ ‫ا‬‫ل‬ ‫ﺗﺣﻣ‬ ‫ﺧﺗﺑﺎر‬ ‫ا‬‫ت‬ ‫ﻟاردﺳﺎ‬ ‫ا‬‫مظ‬ ‫ﻣﻌ‬ ‫ﺳﺗﺧدﻣت‬ ‫(.او‬GDM) ‫ﻟﺣﻣل‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬ ‫ﺑ‬ ‫ﻹﺻﺎﺑﺔ‬ ‫ا‬‫رط‬ ‫ﺧ‬ ‫ﻋاوﻣل‬ ‫ﻟدﯾﮭﺎ‬
.‫ﻟﻌﺎﻟﻣﯾﺔ‬ ‫ﻟﺻﺣﺔا‬ ‫ﻟﻣﻧظﻣﺔا‬ ‫ﻟﺗﺷﺧﯾﺻﯾﺔ‬ ‫ا‬‫ر‬ ‫ﻟﻣﻌﺎﯾﯾ‬ ‫ا‬‫ت‬ ‫ﺑﻘ‬ ‫طو‬، ‫ﻏارﻣﺎ‬ 75 ‫ﺳﺎﻋﺗﯾن‬ ‫ﻟﻣةد‬ ‫ﻟﻔم‬ ‫ا‬‫ق‬ ‫رطﯾ‬

2. :‫اﻻﺳﺗﻧﺗﺎﺟﺎت‬
‫اذھ‬‫س‬ ‫ﯾﻌﻛ‬ ‫ﻷﻓرﯾﻘﯾﺔ.و‬ ‫ا‬‫ةر‬ ‫ﻟﻘﺎ‬ ‫ا‬‫ن‬ ‫ﻣ‬ ‫ﻟﻣﺎﺋﺔ‬ ‫ﻓﻲا‬ 11 ‫ﯾﻌﺎلد‬ ‫ﻣﺎ‬ ‫يأ‬، ‫ﻟﻣﻧﮭﺟﯾﺔ‬ ‫ﻟﻣارﺟﻌﺔا‬ ‫ا‬‫ھذھ‬ ‫ﻓﻲ‬ ‫ﻣﻣﺛﻠﺔ‬ ،‫ناد‬ ‫ﺑﻠ‬ ‫ﺳت‬ ‫وﻛﺎﻧت‬
.‫ﻟﺑﺣث‬ ‫ا‬‫ن‬ ‫ﻣ‬ ‫ﻣزﯾد‬ ‫ﻟﻰ‬ ‫ﻟﺣﺎﺟﺔإ‬ ‫ﻋﻠﻰا‬ ‫ﻟﺿءو‬ ‫ا‬‫ط‬ ‫ﯾﺳﻠ‬ ‫ﻓرﯾﻘﯾﺎو‬ ‫ﻓﻲأ‬ (GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬‫ن‬ ‫ﻋ‬ ‫ﻟﻣﻌفور‬ ‫ﻗﻠﺔا‬ ‫ﻓﮭم‬ ‫ﻟﺿيرور‬ ‫ا‬‫ن‬ ‫ﻓﻣ‬ ،2 ‫ﻟﻧعو‬ ‫ا‬‫ن‬ ‫ﻣ‬ ‫ﻟﺳﻛير‬ ‫ا‬‫ءادو‬ ‫ﺑﺎﻟﺳﻣﻧﺔ‬ ‫ﯾﺗﻌﻠق‬ ‫ﻓﯾﻣﺎ‬ ‫ﻟﻌﺎﻣﺔ‬ ‫ا‬
‫ﻟﻠﺻﺣﺔ‬ ‫ﻟﻣﺗازﯾد‬ ‫ا‬‫ءب‬ ‫ﻟﻌ‬ ‫ﻟﻰا‬ ‫إ‬‫رظ‬ ‫وﺑﺎﻟﻧ‬
.‫ﻟﻔﻌﺎﻟﺔ‬ ‫ا‬‫ل‬ ‫ﻟﺗدﺧ‬ ‫ﺑﺑارﻣﺞا‬ ‫ﻟﻠﺳﻣﺎح‬ ‫ﻓرﯾﻘﯾﺎ‬ ‫ﻓﻲأ‬ (GDM) ‫ﻟﺣﻣﻠﻲ‬ ‫ا‬‫ير‬ ‫ﻟﺳﻛ‬ ‫ا‬‫ءاد‬‫ىد‬ ‫ﻣ‬
------------------------
‫ﺗرﺟﻣﺔاذھ‬ ‫ﺟرﯾت‬ ‫أ‬‫د‬ ‫ﻗ‬ ‫ﻹﻧﺟﻠﯾزﯾﺔ.و‬ ‫ا‬‫ر‬ ‫ﻏﯾ‬ ‫ﻟطﺑﯾﺔ‬ ‫ا‬‫ثو‬ ‫ﻟﺑﺣ‬ ‫ا‬‫ت‬ ‫ﻟﻣﻘﺎﻻ‬ ‫ﻟﻌﺎﻟﻣﯾﺔ‬ ‫ﻟؤرﯾﺔا‬ ‫ا‬‫م‬ ‫ﻟﻔﮭ‬ ‫ﺗﺟرﺑﺔ‬ ‫ُﺟير‬‫ﻧ‬ ،‫ﻟطﺑﯾﺔ‬ ‫ا‬‫ت‬ ‫ﻟﻣﻛﺗﺑﺎ‬ ‫ا‬‫ء‬ ‫ﻣﻧﺎ‬ ‫أ‬‫ن‬ ‫ﻧﺣ‬ ‫ﻧﺎ‬ ‫ﻟﻠﺟﻣﯾﻊھ‬ ‫ﻟﻣﺗﺎح‬ ‫ا‬‫ل‬ ‫ﻟﻣﻘﺎ‬ ‫ﻟﻰا‬ ‫إ‬‫ط‬ ‫ﺑ‬ ‫ارو‬PubMed ‫ﺑﺑﻣد‬ ‫ﻗﺗﺑﺎس‬ ‫ﻋﻠﻰا‬ ‫ﻹطﻼع‬ ‫ا‬
‫ﯾﻣﻛن‬ ‫ﻣﻌﺗﻣد.و‬ ‫ﻣﺗرﺟم‬ ‫ﺑاوﺳطﺔ‬ ‫اﻟﻣﻠﺧص‬
‫ﻋﻠﻰ‬ ‫و‬،‫ه‬ ‫ﻧﺎ‬ ‫دأ‬‫عور‬ ‫ﻟﻣﺷ‬ ‫ﻋﻠﻰا‬ ‫ﺗﻌﻠﯾﻘﺎﺗك‬ ‫ﺿﺎﻓﺔ‬ ‫ﻓﻲإ‬ ‫ﺗﺗددر‬ ‫.ﻻ‬ https://www.ncbi.nlm.nih.gov/pubmed/24892280
.‫ﻷﺻﻠﯾﺔ‬ ‫ﻟﻠﻐﺔا‬ ‫ا‬‫نو‬ ‫ﯾﺗﻛﻠﻣ‬ ‫َﻣن‬ ‫ِﻣ‬ ‫ﻛﻧت‬ ‫ﻟﺗرﺟﻣﺔاذإ‬ ‫ا‬‫ةدو‬ ‫ﺟ‬
.‫ﻛوﻟودارو‬ ‫ﺟﺎﻣﻌﺔ‬ ،‫ﺻﺣﯾﺔ‬ ‫ﻟ‬ ‫ا‬‫مو‬ ‫ﻟﻌﻠ‬ ‫ﻣﻛﺗﺑﺔا‬ ،‫ﺑﻲ‬ ‫ﻧﺎآ‬ ‫ادو‬‫ر‬ ‫ﻓﻛ‬ ‫وھ‬‫ن‬ ‫--ﻟﯾﻠﯾﺎ‬

3. Gestational diabetes mellitus in Africa: a systematic review
Abstract
BACKGROUND:
Gestational diabetes mellitus (GDM) is any degree of impaired glucose tolerance first recognised during
pregnancy. Most women with GDM revert to normal glucose metabolism after delivery of their babies; however,
they are at risk of developing type 2 diabetes later in life as are their offspring. Determining a country's GDM
prevalence can assist with policy guidelines regarding GDM screening and management, and can highlight areas
requiring research. This systematic review assesses GDM prevalence in Africa.
METHODS AND FINDINGS:
Three electronic databases were searched without language restrictions; PubMed, Scopus and the Cochrane
Library. Thirty-one search terms were searched. Eligible articles defined GDM, stated what GDM screening
approaches were employed and reported GDM prevalence. The reporting quality and risk of bias within each
study was assessed. The PRISMA guidelines for systematic reviews were followed. The literature search identified
466 unique records. Sixty full text articles were reviewed of which 14 were included in the systematic review. One
abstract, for which the full text article could not be obtained, was also included. Information regarding GDM
classification, screening methods and prevalence was obtained for six African countries; Ethiopia (n = 1), Morocco
(n = 1), Mozambique (n = 1), Nigeria (n = 6), South Africa (n= 4) and Tanzania (n = 1). Prevalence figures ranged
from 0% (Tanzania) to 13.9% (Nigeria) with some studies focussing on women with GDM risk factors. Most studies
utilised the two hour 75 g oral glucose tolerance test and applied the World Health Organization's diagnostic
criteria.

4. CONCLUSIONS:
Six countries, equating to 11% of the African continent, were represented in this systematic review. This
indicates how little is known about GDM in Africa and highlights the need for further research. Considering
the increasing public health burden of obesity and type 2 diabetes, it is essential that the extent of GDM is
understood in Africa to allow for effective intervention programmes.
___________________________
We are medical librarians conducting an experiment to understand the global visibility of non-English
medical research articles. The translation for this abstract was performed by a certified translator. The
PubMed citation and link to the whole open access article can be found here
https://www.ncbi.nlm.nih.gov/pubmed/24892280. Please feel free to add your comments below on the
project and, if you are a native-speaker, on the quality of the translation.
--Lilian Hoffecker and Dana Abbey, Health Sciences Library, University of Colorado.